NCT07575048 Assertiveness Training for Communication Skills
| NCT ID | NCT07575048 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Amasya University |
| Condition | Communication |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-03-30 |
| Primary Completion | 2026-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-03-30 with a primary completion date of 2026-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to determine the effect of virtual reality-based assertiveness training on strengthening the communication skills of oncology nurses.
Eligibility Criteria
Inclusion Criteria: * Those who agree to participate in the study, * Those who are 18 years of age or older, * Those who have been working in oncology clinics for at least 6 months. Exclusion Criteria: * Those who gave incomplete answers to the scales used in the study, * Those who have previously participated in assertiveness skills training.
Contact & Investigator
Neşe Uysal
PRINCIPAL INVESTIGATOR
Amasya University
Frequently Asked Questions
Who can join the NCT07575048 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Communication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07575048 currently recruiting?
Yes, NCT07575048 is actively recruiting participants. Contact the research team at nese.uysal@amasya.edu.tr for enrollment information.
Where is the NCT07575048 trial being conducted?
This trial is being conducted at Amasya, Turkey (Türkiye).
Who is sponsoring the NCT07575048 clinical trial?
NCT07575048 is sponsored by Amasya University. The principal investigator is Neşe Uysal at Amasya University. The trial plans to enroll 60 participants.